Impact of Dupilumab for Severe Asthma on Fatigue, Quality of Life, Work Productivity, and Activity

20250 citationsJournal Articlehybrid Open Access

Authors

L. Havé · Medisch Centrum Leeuwarden

Karin B. Fieten · Nederlands Astmacentrum Davos

Fleur L. Meulmeester · Leiden University Medical Center

Els J.M. Weersink · Amsterdam Neuroscience

Pieter-Paul Hekking · Sint Franciscus Gasthuis

Sarah Bendien · Haga Hospital

Arnoud F Aldenkamp

Abstract

Fatigue, QoL, and work and activity impairment improved following dupilumab initiation, though most patients did not achieve clinically relevant improvements. Effects on fatigue and work and activity impairment appear less pronounced compared with asthma symptom control, possibly due to irreversible impairments in some patients.

Topics & Keywords

Dermatology and Skin Diseases Asthma and respiratory diseases Psoriasis: Treatment and Pathogenesis

Publication Details

Published in: The Journal of Allergy and Clinical Immunology In Practice

Volume 14, Issue 3, pp. 656-665.e9

DOI: 10.1016/j.jaip.2025.11.015

Field-Weighted Citation Impact: 0.00

Command Palette

Impact of Dupilumab for Severe Asthma on Fatigue, Quality of Life, Work Productivity, and Activity

Authors

Abstract

Topics & Keywords

Publication Details